Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 1, 2010, Pages 56-61

  Pahl, Madeleine V ^a   Vaziri, Nosratola D ^a   Yuan, Jun ^a   Adler, Sharon G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; HEMATOPOIETIC GROWTH FACTOR INDUCIBLE NEUROKININ 1; INTERLEUKIN 10; INTERLEUKIN 6; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UREA;

ADULT; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL TRANSFORMATION; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DOWN REGULATION; HEMODIALYSIS PATIENT; HUMAN; IN VIVO STUDY; KIDNEY FAILURE; MACROPHAGE; MONOCYTE; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; UREA BLOOD LEVEL; UREMIA;

CELLS, CULTURED; HUMANS; KIDNEY FAILURE, CHRONIC; MACROPHAGES; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; UP-REGULATION;

EID: 75749148813     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03390509     Document Type: Article

References (29)

1. Safadi F, Xu J, Smock S, Rico M, Owen T, Popoff S: Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 84: 12-26, 2001
2. Haralanova-Ilieva B, Ramadori G, Armbrust T: Expression of osteoactivin in rat and human liver and isolated rat liver cells. J Hepatol 42: 565-572, 2005
3. Shikano S, Bonkobara M, Zukas PK, Ariizumi K: Molecular cloning of dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparin sulfate. J Biol Chem 271: 8125-8134, 2001
4. Bandari PS, Qian J, Yehia G, Joshi D, Maloof PB, Potian J, Oh H, Gascon P, Harrison J, Rameshwar P: Hematopoietic growth factor inducible neurokinin-1 (HGFIN) gene: A transmembrane protein that is similar to neurokinin-1 interacts with substance. Regul Pept 111: 169-178, 2003
5. Bachner D, Schroder D, Gross G: mRNA expression of the murine glycoprotein (transmembrane) nmb(Gpnmb) gene is linked to the developing retinal pigment epithelium and iris. Brain Res Gene Expr Patterns 1: 159-165, 2002
6. Selim A, Abdelmagid S, Kanaan R, Smock S, Owen T, Popoff S, Safadi F: Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr 13: 265-275, 2003
7. Owen T, Smock S, Prakash S, Pinder L, Brees D, Krull D, Castleberry T, Clancy Y, Marks S Jr, Safadi F, Popoff S: Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 13: 205-220, 2003
8. Weterman M, Ajubi N, van Dinter I, Degen W, van Muijen G, Ruitter D, Bloemers H: nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60: 73-81, 1995
9. Nomiyama H, Egami K, Wada N, Tou K, Horiuchi M, Matsusaki H, Miura R, Yoshie O, Kukita T: Identification of genes differentially expressed in osteoclast-like cells. J Interferon Cytokine Res 25: 227-231, 2005
10. Abdelmagid S, Barbe M, Arango-Hisijara I, Owen T, Popoff S, Safadi F: Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function. J Cell Physiol 210: 26-37, 2007
11. Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT: Transcriptional profiling of bone regeneration: Insight into the molecular complexity of wound repair. J Biol Chem 277: 30177-30182, 2002
12. Ripoll VM, Irvine KM, Ravasi T, Sweet MJ, Hume D: GPNMB is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178: 6557-6566, 2007
13. Chung J, Sato K, Dougherty I, Cruz Jr P, Ariizumi K: DC-HIL is a negative regulator of T lymphocyte activation. Blood 109: 4320-4327, 2007
14. Chung JS, Dougherty I, Cruz PD Jr, Ariizumi K: Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol 179: 5778-5784, 2007
15. Efstratiadis G, Tziomalos K, Mikhailidis DP, Athyros VG, Hatzitolios A: Atherogenesis in renal patients: A model of vascular disease? Curr Vasc Pharmacol 6: 93-107, 2008
16. Kovesdy CP, Kalantar-Zadeh K: Novel targets and new potential: Developments in the treatment of inflammation in chronic kidney disease. Expert Opin Investig Drugs 17: 451-467, 2008
17. Kovesdy CP, Mehrotra R, Kalantar-Zadeh K: Battleground: Chronic kidney disorders mineral and bone disease - Calcium obsession, vitamin D, and binder confusion. Clin J Am Soc Nephrol 3: 168-173, 2008
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001
19. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9[Suppl]: S16-S23, 1998
20. Vaziri ND: Oxidative stress in chronic renal failure: The nature, mechanism and consequences. Semin Nephrol 24: 469-473, 2004
21. Pfaffl MA: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001
22. Jofre R, Rodriguez-Benitez P, Lopez-Gomez JM, Perez-Garcia R: Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol 17[Suppl 3]: S274-S280, 2006
23. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences. Nephrol Dial Transplant 24: 948-955, 2008
24. Porazko T, Kuzniar J, Kusztal M, Kuzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M: IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant 24: 589-596, 2008
25. Al-Aly Z: Arterial calcification: A tumor necrosis factoralpha mediated vascular Wnt-opathy. Transl Res 151: 233-239, 2008
26. London GM, Marchais SJ, Guerin AP, Metivier F: Arteriosclerosis, vascular calcifications, and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14: 525-531, 2005
27. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, deVernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004
28. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809, 1993
29. Towler DA: Calciotropic hormones and arterial physiology: "D"-lightful insights. J Am Soc Nephrol 18: 369-373, 2007